Chiome Bioscience AAQS

Mitä Chiome Bioscience tekee? Chiome Bioscience, Inc. operates in Shibuya-Ku, Tokyo-To and generates revenue through two distinct business segments focused on antibody drug development. The Drug Discovery segment conducts research and development of specific antibodies based on new antigens and mechanisms, subsequently licensing these assets to pharmaceutical companies. This approach allows the firm to monetize its proprietary technology and scientific findings directly through licensing agreements. The Drug Discovery Support segment complements this by developing lead antibodies for therapeutic drugs in collaboration with pharmaceutical companies in Japan and overseas. Through these partnerships, the company provides specialized development services that support the creation of new therapeutic agents. Both segments leverage the company's Autonomous Diversifying Library (ADLib) system to facilitate the creation and refinement of antibody drugs for its clients. Chiome Bioscience on yksi Eurpooliin suosituimmista yhtiöistä.